AbbVie ducks bolt-on trend and agrees Allergan mega-merger

New paediatric use for Allergan's biosimilar-threatened Boto...

Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity.

FDA approves Herceptin biosimilar as US patent expires

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.

SMC approves medicines for breast cancer, skin cancer, schiz...

The Scottish Medicines Consortium (SM

Collaborating to fight NASH

Eric Hughes, Global Development Unit head at Novartis for Immunology, Hepatology & Dermatology, believes that collaboration is going to be key to finally finding a treatment for non

Discontent at Allergan over CEO's chairman role - report

There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.